Courier Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.6M | Buy |
4,669
+10
| +0.2% | +$10.2K | 0.28% | 92 |
|
|
2026
Q1 | $4.29M | Buy |
4,659
+2
| +0% | +$2.03K | 0.24% | 97 |
|
|
2025
Q4 | $5M | Sell |
4,657
-54
| -1% | -$51.6K | 0.28% | 92 |
|
|
2025
Q3 | $3.59M | Sell |
4,711
-59
| -1% | -$43.9K | 0.21% | 109 |
|
|
2025
Q2 | $3.72M | Sell |
4,770
-6
| -0.1% | -$4.66K | 0.23% | 106 |
|
|
2025
Q1 | $3.94M | Sell |
4,776
-44
| -0.9% | -$36.6K | 0.26% | 99 |
|
|
2024
Q4 | $3.72M | Sell |
4,820
-262
| -5% | -$217K | 0.26% | 94 |
|
|
2024
Q3 | $4.5M | Buy |
5,082
+41
| +0.8% | +$36.9K | 0.31% | 78 |
|
|
2024
Q2 | $4.56M | Buy |
5,041
+80
| +2% | +$64K | 0.36% | 61 |
|
|
2024
Q1 | $3.86M | Sell |
4,961
-10
| -0.2% | -$7.12K | 0.28% | 81 |
|
|
2023
Q4 | $2.9M | Sell |
4,971
-382
| -7% | -$223K | 0.22% | 100 |
|
|
2023
Q3 | $2.88M | Sell |
5,353
-82
| -2% | -$42.3K | 0.24% | 93 |
|
|
2023
Q2 | $2.55M | Buy |
5,435
+4,245
| +357% | +$1.78M | 0.2% | 107 |
|
|
2023
Q1 | $409K | Sell |
1,190
-9
| -0.8% | -$3.04K | 0.05% | 205 |
|
|
2022
Q4 | $438K | Hold |
1,199
| – | – | 0.05% | 191 |
|
|
2022
Q3 | $388K | Buy |
1,199
+50
| +4% | +$15.8K | 0.05% | 198 |
|
|
2022
Q2 | $372K | Hold |
1,149
| – | – | 0.04% | 202 |
|
|
2022
Q1 | $329K | Hold |
1,149
| – | – | 0.03% | 227 |
|
|
2021
Q4 | $317K | Hold |
1,149
| – | – | 0.03% | 240 |
|
|
2021
Q3 | $265K | Buy |
1,149
+37
| +3% | +$9.13K | 0.03% | 270 |
|
|
2021
Q2 | $255K | Sell |
1,112
-350
| -24% | -$70.3K | 0.02% | 276 |
|
|
2021
Q1 | $273K | Buy |
+1,462
| New | +$286K | 0.03% | 260 |
|
|
2015
Q4 | – | Sell |
-3,894
| Closed | -$326K | – | 269 |
|
|
2015
Q3 | $326K | Sell |
3,894
-1,030
| -21% | -$87K | 0.07% | 192 |
|
|
2015
Q2 | $411K | Buy |
4,924
+1,611
| +49% | +$123K | 0.08% | 169 |
|
|
2015
Q1 | $241K | Sell |
3,313
-250
| -7% | -$17.8K | 0.05% | 239 |
|
|
2014
Q4 | $246K | Sell |
3,563
-70
| -2% | -$4.72K | 0.05% | 243 |
|
|
2014
Q3 | $236K | Sell |
3,633
-78
| -2% | -$4.94K | 0.05% | 246 |
|
|
2014
Q2 | $231K | Sell |
3,711
-8
| -0.2% | -$477 | 0.05% | 251 |
|
|
2014
Q1 | $219K | Buy |
+3,719
| New | +$208K | 0.05% | 257 |
|
|
2013
Q4 | – | Sell |
-5,313
| Closed | -$267K | – | 288 |
|
|
2013
Q3 | $267K | Sell |
5,313
-1,280
| -19% | -$67K | 0.06% | 225 |
|
|
2013
Q2 | $324K | Buy |
+6,593
| New | +$359K | 0.08% | 188 |
|
Other funds holding LLY
SC
Courier Capital's LLY Position: Q2 2026 in Review
Courier Capital increased its Eli Lilly (LLY) stake by 0.21% in Q2 2026, buying an estimated $10.2K and bringing the position to 4,669 shares worth $5.6M. The position accounts for 0.28% of the portfolio, ranked #92.
Courier Capital first reported a position in LLY in Q2 2013 and has held it in 31 quarters since. 2,216 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Courier Capital held 4,669 shares of Eli Lilly worth $5.6M as of Q2 2026.
- Courier Capital bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
- Eli Lilly made up 0.28% of Courier Capital's portfolio in Q2 2026, its #92 holding.
- Courier Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 31 quarters since.
- 2,216 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Courier Capital's 13F filing for Q2 2026, filed 16 Jul 2026.